Friday 6 November 2026 Export RVMD’s income statement to Excel — free account

Revolution Medicines, Inc.

Revolution Medicines, Inc.’s revenue for fiscal 2023 (year ended December 2023) was $11.6 million, down 67.3% from fiscal 2022.

Revenue: +1,188.7%
EPS: −18.0%
Free cash flow: −99.1%
Total debt: +322.7%

Quarter to September 2026, against a year earlier

192.39 14.74 +8.30%

Follow RVMD

Alert me

Market cap: $38.1B
P/E: 0.0×
Fwd P/E: −11.9×
Dividend yield: —
F-score: 4/9
Altman Z: 7.73
Beneish M: −4.29
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Revolution Medicines, Inc. (RVMD) P/E ratio

Alert me on P/E ratio

Revolution Medicines, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/RVMD/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Revolution Medicines, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/RVMD/metrics/pe-ratio">Revolution Medicines, Inc. (RVMD) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	0.0×	—
FY2019	0.0×	—
FY2018	0.0×	—

Period	P/E ratio	Change
Sep 2026	0.0×	—
Dec 2023	0.0×	—
Jun 2023	0.0×	—
Mar 2023	0.0×	—
16 more quarters	Free account

Against its own ten years

Low 0.0× High 0.0×

Ten-year median 0.0×

Current reading's percentile 100

Company	P/E ratio
ROIV Roivant Sciences Ltd. compare	n/m
BNTX BioNTech SE Sponsored ADR compare	n/m
RVMD Revolution Medicines, Inc.	n/m
INSM Insmed, Inc. compare	n/m
ARGX argenex SE compare	29.8×
GMAB Genmab A/S Sponsored ADR compare	41.7×
RPRX Royalty Pharma PLC compare	44.8×
INCY Incyte Corporation compare	56.3×
ONC BeOne Medicines Ltd. - Sponsored ADR compare	65.9×
Biotechnology industry median	10.3×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Revolution Medicines, Inc. (RVMD) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on RVMD

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on RVMD

Stockrow Weekly